Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The exoskeleton and intestinal tract of the head louse (Pediculus humanus capitis) represent the primary physiological interfaces for pediculicidal interventions. The exoskeleton is a complex chitinous structure protected by a lipid-rich epicuticle that regulates water balance and houses spiracles, the insect's respiratory openings [Source: Wikipedia, 'Head louse']. The intestinal tract is responsible for the processing of human blood meals and serves as the site of action for ingested pediculicides that target the louse's nervous system [Source: CDC, 'Lice - Head Lice - Treatment']. Modern therapeutic strategies often focus on the physical disruption of these structures—such as using silicone oils to block spiracles or surfactants to dissolve the waxy coating—to overcome widespread resistance to traditional neurotoxic agents like permethrin [Source: PubMed: PMC5165061]. These anatomical targets are essential for the survival of the parasite, making them critical focal points for both over-the-counter and prescription treatments for pediculosis capitis. Furthermore, the intestinal tract's role in blood feeding makes it a vulnerable pathway for systemic drugs like ivermectin, which can paralyze the louse by binding to glutamate-gated chloride channels [Source: StatPearls, 'Pediculosis Capitis'].
Pediculicides targeting these structures act through physical occlusion of respiratory spiracles leading to asphyxiation (e.g., dimeticone, benzyl alcohol), dissolution of the protective waxy epicuticle leading to fatal dehydration (e.g., isopropyl myristate), or via systemic absorption of neurotoxins during blood feeding that target the parasite's nervous system (e.g., ivermectin, malathion) [Source: StatPearls, 'Pediculosis Capitis'; PubMed: PMC3336651].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Head louse exoskeleton and intestinal tract.